PCMag Australia

IRIScan Book 7

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more ...

Earlier use of CARVYKTI® (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 Data suggest ...

In-Memory Database Market to Surpass USD 59.58 Billion by 2033, Owing to Rising Demand for Real-Time Data Processing | SNS Insider

The In-Memory Database Market is expanding as industries adopt high-speed, low-latency data processing, with the U.S. segment increasing from USD 5.27 billion in 2025E to USD 17.67 billion by 2033 ...

Labor Management System Market to Hit USD 7.35 Billion by 2033, Driven by Rising Workforce Efficiency Needs and Cost Optimization | SNS Insider

The labor management system market is expanding as organizations adopt real-time tracking, automated scheduling, and cloud-based workforce tools to boost efficiency and control rising labor costs, ...